Skip to main content

Mosaic ImmunoEngineering Inc.

CPMV
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000836564

No open-market purchases or sales by Mosaic ImmunoEngineering Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.

Key figures

Market capNo recent closing price
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026
0
13F valueReported value at the end of Q3 2026
$0
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2026
–
No comparable prior period
Net income, FY2026
-$687.8K
No comparable prior period
Free cash flow, FY2026
–
No comparable prior period
Revenue, Q2 FY2027
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
521
Shares sold short
Change
+400
+330.6% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding CPMV, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding CPMV at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Mosaic ImmunoEngineering Inc. insiders from Form 4, newest first.

No open-market purchases or sales by Mosaic ImmunoEngineering Inc. insiders are on file.

Top 10 13F holders, Q3 2026

View all: Top 10 13F holders, Q3 2026

The largest institutional positions in Mosaic ImmunoEngineering Inc. at the end of Q3 2026; share changes are against Q2 2026.

No institution reported holding CPMV in 13F filings for Q3 2026.